Tracking heart rhythms and complications in arrhythmogenic cardiomyopathy
Part of Genetic & congenital, Heart & circulation clinical trials.
This study is a registry that collects information from people with arrhythmogenic cardiomyopathy who have an ICD. The goal is to learn more about the condition, its heart rhythm complications, and how the ICD works, which may help improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with arrhythmogenic cardiomyopathy, which is a heart muscle condition that can cause dangerous irregular heartbeats.
- You have an implantable cardioverter-defibrillator (ICD), a device that helps control dangerous heart rhythms.
- You have had a documented episode of a fast, dangerous heart rhythm, which was recorded by your ICD or an ECG.
- You are able to attend regular heart check-ups and ICD checks.
- You don't have significant coronary artery disease (blockages), significant heart valve disease, congenital heart defects, or certain conditions like sarcoidosis or amyloidosis.
- You haven't had chemotherapy that might have damaged your heart.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people who are newly diagnosed with a dangerous heart rhythm called ventricular tachycardia (VT) and who are getting an implantable cardioverter-defibrillator (ICD). It may help improve how patients are followed in the ICD clinic after the initial hospitalization.
This study looks at how the heart's electrical signals can help doctors understand if treatments prevent dangerous heart rhythms in active people. It involves people with or without heart devices like ICDs or pacemakers, and may help improve care for active individuals with heart conditions.
This study looks at an implantable defibrillator (ICD) strategy in people who survived a cardiac arrest caused by an abnormal rhythm (ventricular fibrillation or ventricular tachycardia). It aims to reduce the risk of another dangerous rhythm after the blocked heart arteries are fully treated.
This study looks at whether a supervised exercise and rehabilitation program can help people who have a genetic heart condition called arrhythmogenic cardiomyopathy. The program is designed to be safe for people with a higher genetic risk and aims to improve overall heart health.
This study looks at whether a special type of defibrillator that sits under the skin is a good option for people with arrhythmogenic cardiomyopathy, a heart condition that can cause dangerous heart rhythms. It aims to help doctors decide who might benefit from this device and when.
This study looks at people with a genetic heart muscle condition called cardiomyopathy, which can cause irregular heartbeats. By studying your condition, doctors hope to better understand how it develops, how to predict its course, and how to improve diagnosis and treatment.
Hear when a new Arrhythmogenic Cardiomyopathy (AC, ARVD/C) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.